Perfect Storm - Acrylamide or Proposition 65 I posted this a few years ago..... and thought it was worth posting it again. I had a look at their RECENT MD&A and they are still talking about this as a major risk to their company's moving forward.... I will post the link but grabbed the 2 specific pages from the MD& A and posted below: First my post from a year or so ago....
.Acrylamide or Proposition 65................ has Corporations REALLY CONCERNED
.
One such Corporation is PepsiCo who is Gorilla in the market place with several divisions and brands.....
.
https://www.pepsico.com/Brands.html
- Pepsi
- Frito Lay
- Tropicana
- Quaker
- Gatorade
.
In the PepsiCo Annual Report to Shareholders, they spell out that Acrylamide is a significant risk to their business.
.
The fact is that the potato industry, along with other industry leaders, such as PepsiCo.... are keen to address this issue. These items don’t just make it into their filed MD&A statements unless they are significant in nature. I think it GOES WITHOUT SAYING no one likes to disclose this type of information to their shareholders or the public for that matter.... especially the big consumer companies.
.
I found this of significant interest...... and why I feel Functional Technologies is onto something REALLY BIG WITH THIS PATENTED SCIENCE....
.
PepsiCo Annual Report to Shareholders MD&A – “Our Business Risks” Section
.
Highlights of PepsiCo article:
.
- PepsiCo, in its Annual Report to shareholders, specifically singles out Acrylamide as an example of risk to its business.
.
- “Changes in the legal and regulatory environment could limit our business activities, increase our operating costs, reduce demand for our products or result in litigation.”
.
- “For example, studies are underway by various regulatory authorities and others to assess the effect on humans due to acrylamide in the diet. Acrylamide is a chemical compound naturally formed in a wide variety of foods when they are cooked (whether commercially or at home), including french fries, potato chips, cereal, bread and coffee. It is believed that acrylamide may cause cancer in laboratory animals when consumed in significant amounts. If consumer concerns about acrylamide increase as a result of these studies, other new scientific evidence, or for any other reason, whether or not valid, demand for our products could decline and we could be subject to lawsuits or new regulations that could affect sales of our products, any of which could have an adverse effect on our business, financial condition or results of operations.”
.
- “We are also subject to Proposition 65 in California, a law which requires that a specific warning appear on any product sold in California that contains a substance listed by that State as having been found to cause cancer or birth defects. If we were required to add warning labels to any of our products or place warnings in certain locations where our products are sold, sales of those products could suffer not only in those locations but elsewhere.”
,
https://www.pepsico.com/annual09/financialContent_mda_our_business_risks.html
======
California Proposition 65
.
Proposition 65 (formally titled "The Safe Drinking Water and Toxic Enforcement Act of 1986") is a California law that has been in effect since 1986 to promote clean drinking water and keep toxic substances that cause cancer and birth defects out of consumer products. It is administered by Cal/EPA's California Office of Environmental Health Hazard Assessment (OEHHA). Proposition 65 regulates substances listed by California as causing cancer or birth defects or other reproductive harm in two ways. The first regulatory arm of Proposition 65 prohibits businesses from knowingly discharging listed substances into drinking water sources, or onto land where the substances can pass into drinking water sources. The second regulatory arm of Proposition 65 prohibits businesses from knowingly exposing individuals to listed substances without providing a clear and reasonable warning.
.
https://en.wikipedia.org/wiki/Proposition_65
.
/www.pepsico.com/annual11/downloads/PEP_AR11_2011_Annual_Report.pdf">https://www.pepsico.com/annual11/downloads/PEP_AR11_2011_Annual_Report.pdf/i155.photobucket.com/albums/s288/Tommer3/tommer/feb29-001.jpg" style="width: 620px; height: 802px;" />
.
.
--------
Functional Technologies Corp is an advanced company who has developed a scientific approach to reducing acrylamide in tradition yeasts:
--------
.
And as of late - Functional Technologies has made some significant head way....... there last few news releases says it all: Major progess in my opinion. Good times ahead !!!!
.
-----------
Functional Technologies Signs Agreement with Leading Global Yeast Producer, Production of Acrylamide-Preventing Yeast to Commence
.
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/22/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") is pleased to announce it has entered an agreement with a global, industry leader in yeast production and technologies (the "Yeast Producer") for the optimization and commercial grade-production of the Company's Acryleast? acrylamide-preventing (AP) yeasts. This agreement, which also contains certain commercial terms, enables the producer to begin the manufacture of the AP yeasts so that pilot scale volumes can, and currently are being produced and shipped to the Company's food processing collaborators, which collectively represent some of the world's largest and most recognized multinational food companies. Acryleast? is Functional Technologies' platform solution that has been demonstrated to prevent or reduce the formation of acrylamide, a carcinogenic as well as reproductive and neurological toxic byproduct that is prevalent in many widely consumed food products.
.
Under this agreement, Functional Technologies has now shipped commercial strains of its Acryleast? yeasts to the Yeast Producer for scale production. The Yeast Producer has also been granted a non-exclusive right of negotiation to obtain an exclusive license to commercialize the Company's Acryleast? technologies for specific food sectors, such as in the form of longer term license agreements and/or large scale production and supply of AP yeasts.
.
The agreement stipulates, that once right of negotiation is triggered, these negotiations are required to be completed within a limited time frame.
.
Functional Technologies believes that the arrangement for the AP yeasts to be produced in an expedited manner, which requires significant coordination and capital and resource allocation on the Yeast Producer's part, reflects not only a commitment of the Yeast Producer in collaborating with Functional Technologies, but also validates the appeal and significance of the commercial opportunity associated with the Acryleast? technology.
.
The scale of Acryleast? production to be undertaken by this collaboration will enhance the ability of food producers to conduct their own pilot testing to confirm the effectiveness of the Company's AP yeasts, at scale, in reducing acrylamide under commercial processing conditions. Successful confirmation of the performance of Acryleast? yeasts in a variety of food applications, under industrial conditions, represents an important milestone to drive adoption of the AP yeasts by various industries.
.
"This agreement, which follows the earlier letter of commitment between the parties, is a significant step towards validating the effectiveness and utility of the Company's innovative and proprietary acrylamide-preventing yeasts at an industrial and commercial level," said Mr. Howard Louie, Chief Business Development Officer of Functional Technologies. "We are pleased to continue to solidify our relationship with this industry leader in yeast technologies and production, and expand the opportunities associated with our proprietary yeast technologies. Obtaining access to the production of our products at a high standard of quality assurance at scale, will allow us to move through pilot scale production runs with our trial partners/customers allowing the product to be fully adopted into their product mix. The news that we are collaborating with a global leader in yeast production for this stage of product testing allows the global food producers with which we are running trials and product integration the comfort that their future needs on any scale in any region can more readily be met from a production capacity requirement."
.
About Functional Technologies Corp.
.
Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization ("WHO") as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen supplied (H2S) and the WHO classified probable carcinogen, acrylamide - both by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. For more information, please visit our website at www.functionaltechcorp.com.
.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY HAVE THIS RELEASE.
.
Contacts:
Functional Technologies Corp.
Geoff Lee
VP Business Development
+1.604.648.2200
glee@functionaltechcorp.com
www.functionaltechcorp.com
============
.
Functional Technologies Corp : Functional Technologies Announces Letter of Commitment from Leading Global Yeast Producer for Initial Production and Supply of Acrylamide-Preventing Yeast
.
September 20, 2012
.
Functional Technologies Announces Letter of Commitment from Leading Global Yeast Producer for Initial Production and Supply of Acrylamide-Preventing Yeast
.
Vancouver, BC - September 20, 2012 - Functional Technologies Corp. (TSXV: FEB; OTCQX: FEBTF) (the "Company") is pleased to announce that a global, industry leader in yeast production and yeast technology (the "Yeast Producer") has signed a letter confirming its commitment to supply Functional Technologies with preliminary volumes of the Company's proprietary AcryleastTM yeasts, a platform solution that prevents and reduces the formation of acrylamide. This supply arrangement enables major food processing companies and collaborators, including in the baking, snack food, cereals and potato processing sectors, to evaluate and confirm the feasibility and effectiveness of the AcryleastTM platform in various commercial processes. Successful confirmation of the performance of AcryleastTM yeasts in food applications under industrial processing conditions is an important milestone to drive the adoption of the Company's yeasts by various industries.
.
The letter also describes the manner of collaboration enabling the two companies to evaluate the production and optimization of AcryleastTM yeasts, how this may be best facilitated by the Yeast Producer, as well as continued assessments of the industrial scale feasibility of Functional Technologies' existing and potential subsequent yeast strains and products for the prevention and reduction of acrylamide in specific food categories. Particulars including which 3rd party production and Yeast Producer-specific manufacturing facilities will be engaged for the production of the AcryleastTM yeasts are also provided in the letter. This is expected to provide end-user collaborators with some level of assurance that the quality of the Company's AP yeast, even at pilot scale volumes, is of commercial and high grade.
.
Collectively, this confirmed commitment provides for the potential for longer term arrangement and agreements, including the large scale production and supply of AcryleastTM yeasts for food processing end-users and customers across a variety of food market segments.
.
"We are pleased to continue to expand our working and strategic relationship with a respected, global leader in innovation and quality, as well as size, to further the commercial potential and distribution of our AP yeast platform," said Mr. Howard Louie, Chief Business Development Officer of Functional Technologies. "With this initial letter of commitment, we look forward to continuing to grow our relationship and working together to enhance the opportunities associated with our proprietary yeast technologies to the benefit of both parties."
.
About Functional Technologies Corp.
.
Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization ("WHO") as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide (H2S) and the WHO classified probable carcinogen, acrylamide - both by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. For more information, please visit our website at www.functionaltechcorp.com.
.
For further information, contact:
Geoff Lee
VP, Business Development
Phone: +1.604.648.2200
Email:glee@functionaltechcorp.com